1. Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition
   Pingde Zhang et al, 2017, J Neurooncol CrossRef
2. Effects of anticancer drugs on glia–glioma brain tumor model characterized by acoustic impedance microscopy
   Thomas Tiong Kwong Soon et al, 2017, Jpn. J. Appl. Phys. CrossRef
3. Glioblastoma Multiforme Therapy and Mechanisms of Resistance
   Yulian Ramirez et al, 2013, Pharmaceuticals CrossRef
4. Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response.
   Sabine Hombach-Klonisch et al, 2018, Pharmacol Ther CrossRef
5. Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas
   Alfeu Zanotto-Filho et al, 2015, Cancer Letters CrossRef
6. The activation of the G protein-coupled estrogen receptor (GPER) inhibits the proliferation of mouse melanoma K1735-M2 cells
   Mariana P.C. Ribeiro et al, 2017, Chemico-Biological Interactions CrossRef
7. Verapamil potentiates anti-glioblastoma efficacy of temozolomide by modulating apoptotic signaling
   Farina Hanif et al, 2018, Toxicology in Vitro CrossRef
8. SOX3 can promote the malignant behavior of glioblastoma cells
   Jelena Marjanovic Vicentic et al, 2018, Cell Oncol. CrossRef
9. Autophagic and Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma
   Cristina Trejo-Solís et al, 2018, IJMS CrossRef
10. Progesterone Treatment Attenuates Glycolytic Metabolism and Induces Senescence in Glioblastoma
    Fahim Atif et al, 2019, Sci Rep CrossRef
11. null
    Jiri Sana et al, 2014 CrossRef
12. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Zhen Liu et al, 2019, World Neurosurg CrossRef
13. Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma
    Navjot Kaur et al, 2013, Molecular and Cellular Neuroscience CrossRef
14. Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway.
    Howard A Burris, 2013, Cancer Chemother Pharmacol CrossRef
15. PKC signaling in glioblastoma.
    Anália do Carmo et al, 2013, Cancer Biol Ther CrossRef
16. MicroRNAs involved in chemo- and radioresistance of high-grade gliomas
    Andrej Besse et al, 2013, Tumor Biol. CrossRef
17. The combination of the antiestrogen endoxifen with all-trans-retinoic acid has anti-proliferative and anti-migration effects on melanoma cells without inducing significant toxicity in non-neoplasic cells.
    Mariana P C Ribeiro et al, 2013, Eur. J. Pharmacol. CrossRef
18. Restoration of Sensitivity in Chemo — Resistant Glioma Cells by Cold Atmospheric Plasma
    Julia Köritzer et al, 2013, PLoS ONE CrossRef
19. The combination of glutamate receptor antagonist MK-801 with tamoxifen and its active metabolites potentiates their antiproliferative activity in mouse melanoma K1735-M2 cells
    Mariana P.C. Ribeiro et al, 2014, Experimental Cell Research CrossRef
20. Concomitant treatment with pertussis toxin plus temozolomide increases the survival of rats bearing intracerebral RG2 glioma
    Roxana Magaña-Maldonado et al, 2014, J Cancer Res Clin Oncol CrossRef
21. Mechanism of temozolomide-induced antitumour effects on glioma cells.
    Wei Shen et al, 2014, J. Int. Med. Res. CrossRef
22. Anti-tumor effects of progesterone in human glioblastoma multiforme: Role of PI3K/Akt/mTOR signaling
    Fahim Atif et al, 2015, The Journal of Steroid Biochemistry and Molecular Biology CrossRef
23. Current evidence of temozolomide and bevacizumab in treatment of gliomas.
    Danop Nanegrungsunk et al, 2015, Neurol Res CrossRef
24. Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma.
    Reshma Rangwala et al, 2014, Autophagy CrossRef
25. Selenium Action in Neuro-Oncology
    Eduard Yakubov et al, 2014, Biol Trace Elem Res CrossRef
26. Pine (Pinus morrisonicola Hayata) Needle Extracts Sensitize GBM8901 Human Glioblastoma Cells to Temozolomide by Downregulating Autophagy and O6-Methylguanine-DNA Methyltransferase Expression
    Chia-Leng Liao et al, 2014, J. Agric. Food Chem. CrossRef
27. Tamoxifen in combination with temozolomide induce a synergistic inhibition of PKC-pan in GBM cell lines
    Joana Balça-Silva et al, 2015, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
28. Temozolomide may induce cell cycle arrest by interacting with URG4/URGCP in SH-SY5Y neuroblastoma cells
    Veli Çıtışlı et al, 2015, Tumor Biol. CrossRef
29. RLIP76 Depletion Enhances Autophagic Flux in U251 Cells
    Chenran Zhang et al, 2017, Cell Mol Neurobiol CrossRef
30. Autophagy inhibitors chloroquine and LY294002 enhance temozolomide cytotoxicity on cutaneous melanoma cell lines in vitro
    Oxana O. Ryabaya et al, 2017, Anti-Cancer Drugs CrossRef
31. Glioblastoma entities express subtle differences in molecular composition and response to treatment
    Joana Balça-Silva et al, 2017 CrossRef
32. WNK2 Inhibits Autophagic Flux in Human Glioblastoma Cell Line
    Ana Laura Vieira Alves et al, 2020, Cells CrossRef
33. Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions
    Agnieszka Belter et al, 2020, PLoS ONE CrossRef
34. Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells
    Barbara Banelli et al, 2017, Oncotarget CrossRef
35. Necroptosis is associated with low procaspase-8 and active RIPK1 and -3 in human glioma cells
    Sara Melo-Lima et al, 2014, Oncoscience CrossRef
36. Celecoxib substituted biotinylated poly(amidoamine) G3 dendrimer as potential treatment for temozolomide resistant glioma therapy and anti-nematode agent
    Łukasz Uram et al, 2020, European Journal of Pharmaceutical Sciences CrossRef
37. The Novel Antitumor Compound HCA Promotes Glioma Cell Death by Inducing Endoplasmic Reticulum Stress and Autophagy
    Roberto Beteta-Göbel et al, 2021, Cancers CrossRef
38. The implications of nitric oxide metabolism in the treatment of glial tumors
    Marek Mazurek et al, 2021, Neurochemistry International CrossRef
39. Fundamental signaling pathways for glioblastoma drug resistance and developing robust organoid models for drug discovery
    Athira Pratap et al, 2022, Organoid CrossRef
40. Temozolomide Resistance: A Multifarious Review on Mechanisms Beyond O-6-Methylguanine-DNA Methyltransferase
    Vanishree Rao et al, 2023, CNSNDDT CrossRef
41. IGF2BP2 modulates autophagy and serves as a prognostic marker in glioma
    Ning Li et al, 2024, Ibrain CrossRef
42. Repurposed Drugs Celecoxib and Fmoc-L-Leucine Alone and in Combination as Temozolomide-Resistant Antiglioma Agents—Comparative Studies on Normal and Immortalized Cell Lines, and on C. elegans
    Łukasz Uram et al, 2024, IJMS CrossRef